The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study

Mattei, Agostino; Fuechsel, Frank G; Bhatta Dhar, Nivedita; Warncke, Sebastian H; Thalmann, George N; Krause, Thomas; Studer, Urs E (2008). The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. European urology, 53(1), pp. 118-25. Amsterdam: Elsevier 10.1016/j.eururo.2007.07.035

[img] Text
1-s2.0-S0302283807009773-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

OBJECTIVES: To map the primary prostatic lymphatic landing sites using a multimodality technique. METHODS: Thirty-four patients with organ-confined prostate cancer (cT1-cT2; cN0) underwent single-photon emission computed tomography fused with data from computed tomography (SPECT/CT) (n=33) or magnetic resonance imaging (SPECT/MRI) (n=1) 1h after ultrasound-guided intraprostatic injection of technecium (Tc-99m) nanocolloid. The presence of lymph nodes (LNs) containing Tc-99m was confirmed intraoperatively with a gamma probe. A backup extended pelvic lymphadenectomy (PLND) was performed to preclude missed primary lymphatic landing sites. The SPECT/CT/MRI data sets were used to generate a three-dimensional projection of each LN site. RESULTS: A total of 317 LNs (median, 10 per patient; range, 3-19) were detected by SPECT/CT/MRI, 314 of which were confirmed by gamma probe. With an "extended" PLND, two thirds of all primary prostatic lymphatic landing sites are resected compared with only one third with a "limited" PLND. CONCLUSIONS: The multimodality technique presented here enables precise mapping of the primary prostatic lymphatic landing sites. PLND for prostate cancer should include not only the external and obturator regions as well as the portions medial and lateral to the internal iliac vessels, but also the common iliac LNs at least up to the ureteric crossing, thus removing approximately 75% of all nodes potentially harbouring metastasis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Thalmann, George, Krause, Thomas Michael, Studer, Urs

ISSN:

0302-2838

ISBN:

17709171

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:04

Last Modified:

20 Jul 2023 16:31

Publisher DOI:

10.1016/j.eururo.2007.07.035

PubMed ID:

17709171

Web of Science ID:

000251956600025

BORIS DOI:

10.48350/27992

URI:

https://boris.unibe.ch/id/eprint/27992 (FactScience: 115413)

Actions (login required)

Edit item Edit item
Provide Feedback